Scarica l'app Stockscreener
4.02
0.99%
-0.04
Dopo l'orario di chiusura:
4.02
Precedente Chiudi:
$4.06
Aprire:
$4.13
Volume 24 ore:
797.13K
Relative Volume:
0.83
Capitalizzazione di mercato:
$511.44M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-44.67
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
+2.03%
1M Prestazione:
+3.08%
6M Prestazione:
+9.54%
1 anno Prestazione:
-25.00%
Intervallo 1D:
$3.93
$4.23
Intervallo di 1 settimana:
$3.75
$4.23
Portata 52W:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.02 | 510.17M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences Inc 8EQ Stock Analysis and ForecastCapital Gains Strategies & Exceptional Profit Portfolio - earlytimes.in
Cytek Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Cytek Biosciences relocates European HQ to Amsterdam’s life sciences district - TradingView
Cytek Biosciences Relocates European Headquarters to New Facility in Amsterdam - MarketScreener
Cytek Biosciences Relocates European Headquarters to Amsterdam, Expanding Operations and Customer Support - Quiver Quantitative
Cytek® Biosciences Expands European Presence with New - GlobeNewswire
Cytek Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth - MarketScreener
Will Cytek Biosciences Inc. see short term momentum2025 Sector Review & Community Consensus Trade Alerts - newser.com
Risk vs reward if holding onto Cytek Biosciences Inc.Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Long term hold vs stop loss in Cytek Biosciences Inc.Quarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
How Cytek Biosciences Inc. stock reacts to inflationary pressures2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Will Cytek Biosciences Inc. stock continue dividend increasesJuly 2025 Summary & Precise Swing Trade Entry Alerts - newser.com
How interest rate cuts could boost Cytek Biosciences Inc. stockMarket Growth Review & AI Driven Price Forecasts - newser.com
Cytek Biosciences' (CTKB) "Sell (E+)" Rating Reiterated at Weiss Ratings - MarketBeat
Using Python tools to backtest Cytek Biosciences Inc. strategies2025 Key Highlights & Smart Swing Trading Alerts - newser.com
Cytek Biosciences (NASDAQ:CTKB) Upgraded to Strong-Buy at Zacks Research - MarketBeat
Cytek Announces Global Reach in Sales of Flow Cytometry Systems | RapidScan | Jan/Feb 2020 - Photonics Spectra
Cytek Biosciences, Inc. $CTKB Shares Bought by Public Employees Retirement System of Ohio - Defense World
Should you wait for a breakout in Cytek Biosciences Inc.July 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Is Cytek Biosciences Inc. stock ready for a breakoutJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
Using data filters to optimize entry into Cytek Biosciences Inc.July 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
How Cytek Biosciences Inc. stock performs in rising dollar environmentTrade Entry Report & Weekly Momentum Picks - newser.com
Cytek Extends its Flow Cytometry Capabilities | BioScan | Jan/Feb 2022 - Photonics Spectra
Cytek Biosciences (NASDAQ:CTKB) Trading Up 8.9%Here's Why - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Full technical analysis of Cytek Biosciences Inc. stockQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - newser.com
Cytek Biosciences Inc Stock Analysis and ForecastEarnings Volatility Patterns & Fast Growing Investment Ideas - earlytimes.in
Cell Analyzer | Cytek Biosciences Inc. | May/Jun 2025 - Photonics Spectra
Cytek Announces Global Reach in Sales of Flow Cytometry Systems | RapidScan | Nov 2019 - Photonics Spectra
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cytek Biosciences Inc Azioni (CTKB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
1.23%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):